In the past, Strabismus (a disease that affects 3% of the population) had a highly subjective diagnostic system that depended heavily on the specialist. This measuring system was so subjective that generated the need of second operations to definitively correct strabismus.
BCN Innova, a spin-off company of SJD Barcelona Children's Hospital, has developed a device (GazeLab) that substantially improves the diagnosis and treatment of Strabismus. Today, the number of second operations performed to achieve the expected outcome has been reduced.
The main benefits are: GazeLab allows for an objective examination with a revolutionary precision that exceeds the prevailing model of subjective measurements conducted up to the present. It reduces the number of second operations by 50%.
- Company founded (2009): BCN Innova
- Worldwide patent
- Marketed since 2013
- Dr. Joan Prat - Head of the Ophthalmology Department in SJd Barcelona Children's Hospital
- Dr. Jaume Pérez Payarols - Innovation and Research Director in SJd Barcelona Children's Hospital